This webinar explores how decisions made during the investigational new drug (IND) stage can impact validation readiness, technology transfer, and regulatory success.
A research team led by Purdue University, with partners Entomol and 1,4Group, has been awarded $2 million from the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results